4//SEC Filing
Werner Sean 4
Accession 0001628280-25-010568
CIK 0000834365other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:14 PM ET
Size
6.7 KB
Accession
0001628280-25-010568
Insider Transaction Report
Form 4
Werner Sean
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-03-03$25.46/sh−136$3,463→ 4,953 total - Sale
Common Stock
2025-03-04$24.03/sh−88$2,115→ 4,865 total
Footnotes (2)
- [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
- [F2]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 09-01-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
Documents
Issuer
BIOLIFE SOLUTIONS INC
CIK 0000834365
Entity typeother
Related Parties
1- filerCIK 0002047541
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:14 PM ET
- Size
- 6.7 KB